Low blood glucose levels (hypoglycemia), including severe hypoglycemia, may occur if this medicine is used with an insulin secretagogue or insulin
Reconstitution Solution is a sterile water-based solution containing 0.9% benzyl alcohol, supplied for use in controlled laboratory and research environments
AOD-9604 is listed on the World Anti-Doping Agency (WADA) Prohibited List and is subject to UK Anti-Doping (UKAD) regulations
Headaches may be persistent and more intense than common tension headaches
Traceable via CAS 137525-51-0 (BPC-157) and CAS 77591-33-4 (TB-500), the product supports transparent documentation and EU-aligned research compliance
In preclinical research, combined administration has demonstrated superior outcomes compared to either peptide administered alone for muscle, tendon, and ligament injuries